Stryker Corporation

Equities

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 01:25:07 2024-05-01 pm EDT 5-day change 1st Jan Change
326.3 USD -3.02% Intraday chart for Stryker Corporation -3.36% +8.70%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
UBS Adjusts Stryker Price Target to $351 From $339, Maintains Neutral Rating MT
BTIG Adjusts Price Target on Stryker to $369 From $366 MT
Piper Sandler Adjusts Price Target on Stryker to $380 From $375 MT
Baird Adjusts Price Target on Stryker to $378 From $367 MT
Stifel Adjusts Price Target on Stryker to $375 From $350 MT
Oppenheimer Adjusts Price Target on Stryker to $360 From $350 MT
Roth MKM Adjusts Price Target on Stryker to $405 From $348 MT
Jefferies Adjusts Price Target on Stryker to $400 From $390, Keeps Buy Rating MT
Bernstein Adjusts Price Target on Stryker to $393 From $385, Keeps Outperform Rating MT
Nephron Research Raises Stryker's Price Target to $400 From $385 MT
Barclays Raises Stryker's Price Target to $376 From $372 MT
Wells Fargo Adjusts Price Target on Stryker to $381 From $364 MT
Stryker lifts 2024 profit forecast on strong demand for medical devices, implants RE
Stryker's Q1 Adjusted EPS, Sales Increase; 2024 EPS Guidance Boosted; Shares Drop After Hours MT
Stryker Guides For 2024 EPS of $11.85-$12.05 on Sales Growth of 8.5%-9.5%, vs CIQ Analyst Consensus of $11.85/Share on Sales of $22.1 Billion MT
Earnings Flash (SYK) STRYKER CORPORATION Reports Q1 Revenue $5.24B, vs. Street Est of $5.11B MT
Stryker Lifts Organic Sales Outlook After 1Q Rise DJ
Transcript : Stryker Corporation, Q1 2024 Earnings Call, Apr 30, 2024
Stryker Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Global markets live: Adidas, Mercedes, McDonalds, Eli Lilly, PayPal, MicroStrategy, Tesla... Our Logo
Truist Securities Adjusts Stryker Price Target to $364 From $345 MT
BTIG Adjusts Stryker's Price Target to $366 From $353 MT
RBC Raises Price Target on Stryker to $386 From $360, Keeps Outperform Rating MT
Penumbra, Inc. : The underdog in healthcare Our Logo
TD Cowen Adjusts Price Target on Stryker to $400 From $365, Maintains Buy Rating MT
Chart Stryker Corporation
More charts
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
336.5 USD
Average target price
370.3 USD
Spread / Average Target
+10.03%
Consensus
  1. Stock Market
  2. Equities
  3. SYK Stock
  4. News Stryker Corporation
  5. Wells Fargo Adjusts Price Target on Stryker to $364 From $336, Keeps Overweight Rating